Engineered High-Strength Bio-Hydrogel as a Multifunctional Platform to Deliver Nucleic Acid for Ameliorating Intervertebral Disc Degeneration

Tao Chen,Qiuping Qian,Pooyan Makvandi,Ehsan Nazarzadeh Zare,Qizhu Chen,Linjie Chen,Zhiguang Zhang,Hao Zhou,Wenxian Zhou,Hui Wang,Xiangyang Wang,Yu Chen,Yunlong Zhou,Ai-Min Wu
DOI: https://doi.org/10.2139/ssrn.4263568
2022-01-01
SSRN Electronic Journal
Abstract:Intervertebral disc degeneration (IVDD) is a leading cause of low back pain. The strategy of delivering nucleic acids with functional materials provides a powerful tool for ameliorating IVDD. However, the immunogenicity of nucleic acid vectors and the poor mechanical property of functional materials greatly limit their effects. Herein, antagomir-204-3p shows low immunogenicity and can effectively inhibit the apoptosis of nucleus pulposus cells. Moreover, a high-strength bio-hydrogel based on zinc-oxidized sodium alginate-gelatin (ZOG) is designed as a multifunctional nucleic acid delivery platform. The ZOG loaded with antagomir-204-3p (ZOGA) exhibits great hygroscopicity, antibacterial activity, biocompatibility, and biodegradability. Meanwhile, ZOGA can be cross-linked with nucleus pulposus tissue to form a high-strength collagen network that is responsible for the improvement of the mechanical property of the intervertebral disc (IVD). Besides, ZOGA provides an advantageous genetic microenvironment, in which antagomir-204-3p can play an efficient role in maintaining the metabolic balance of the extracellular matrix. The results of the radiological and histological analysis demonstrate that ZOGA restores the height of IVD, retains moisture in IVD, and keeps the tissue structure. The ZOGA platform shows sustained release of nucleic acid and its potential application to ameliorate IVDD, which open a path for future studies related to IVD.Funding Information: This work was supported by National Natural Science Foundation of China (82272555), Zhejiang Provincial Natural Science Foundation of China (LGF21H060010), Zhejiang Provincial Traditional Chinese Medicine Science and Technology Program (2020ZB146), Zhejiang Provincial Medical Technology Foundation of China (2022PY071), Wenzhou Public Welfare Science and Technology Project (WIUCASQD2019001), Wenzhou Municipal Science and Technology Bureau (Y20190018). Declaration of Interests: The authors declare no conflict of interest. Ethics Approval Statement: The procedures and treatment were approved by the Experimental Animal Ethics Committee of Wenzhou Institute, University of Chinese Academy of Sciences (Issue No. WIUCAS21101838).
What problem does this paper attempt to address?